Quest and Waters Turn At-Home HPV Into a Routed Care Program

Quest and Waters are building a clinician-ordered at-home HPV program that pairs self-collection with centralized lab processing and routed follow-up.

Updated

What is this trend?

Quest and Waters are turning at-home HPV screening into a clinician-ordered, routed care workflow that links self-collection, centralized lab processing, and follow-up through provider and payer channels.

  • At-home HPV is shifting from convenience to a managed care pathway.
  • Clinician ordering and closed-loop routing are now part of the product.
  • Quest will process mailed or drop-off samples on its automated BD COR system.
  • Distribution will run through providers, consumer channels, and payer gap-in-care programs.
  • Coverage may broaden across commercial, Medicaid, and Medicare plans.

What’s the latest?

How it developed

  1. Decentralized diagnostics become workflow platforms, blood screening enters clinical care, and liquid biopsy turns decision support
    • Regulated Decentralized Diagnostics Are Becoming Workflow Platforms
  2. Companion diagnostics become commercial platforms, FDA makes AI validation the moat, and pathology consolidates
    • Decentralized Testing Expansion
  3. ctDNA Gates Therapy, AI Moves Into Workflow, and Distribution Becomes the New Moat
    • Decentralized Testing Expansion

Go deeper

Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.

Stay ahead in Diagnostics & Informatics

Get the weekly brief in your inbox — the developments, what they mean by vantage, and what to do next.